THE FIRST EXPERIENCE IN THE EMBOLIZATION OF PROSTATIC ARTERIES IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

Introduction. Our first experience in embolization of prostatic arteries at patients with benign prostatic hyperplasia had comprised patients with the symptoms of chronic urinary retention.

Material and methods. The average age of patients (n=3) was 61.0±4 years. Among medical indications to embolization there were dysuria significantly degrading the patients’ life quality and their unwillingness to proceed to transurethral resection. Before the embolization of the prostatic artery, it is necessary to identify the place of its departure and its anastomosis by computed tomography. Successful operation was effectuated without microcatheter guides in 3 cases and with the application of microcatheter guides in 3 cases. For the purposes of embolization there were used spherical embolus HydroPearl sized 400 nm. No complications were reported neither in the operational nor in the post-operational periods.

Results. All patients admitted a decrease in dysuria as well as the improvement in life quality already in 7–15 days after the endovascular invasion. Control ultrasound dopplerography was performed 3 months after intervention. Two patients with embolization showed decrease of prostate volume by 26%, and one patient — by 35%.

Conclusions. Embolization of the prostatic arteries is a promising low-traumatic and safe method for treating patients with benign prostatic hyperplasia. It is necessary to further study its long-term results, to develop an optimized methodology — fast, simple and cheap, but not at the expense of efficiency and safety. 

1. Nоjmark B.A., Torbik D.V. Long-term results of benign prostatic hвperplasia treatment bв superselective embolization of prostatic arteries. Modern problems of science and education. 2016;(6):24. (in Russ.)

2. Ivashchenko V.A., Dyusyubaev A.A. Diagnostics and medicamental correction of lower urinary tract symptoms after tur of benign prostate hypertrophy. Bashkortostan medical journal. 2013;8(2):62–6. (in Russ.)

3. Al-Shukri S.H., Giorgobiani T.G., Amdiy R.E. Disuria after operative therapy of benign prostatic hyperplasia. Nephrology. 2012;16(4):88–93. (in Russ.)

4. Yakovets E.A., Neimark A.I., Karpenko A.A., Yakovets Y.V. Embolisation prostatic artery in the treatment of the BPH patients with the high surgical risk. Andrology and genital surgery. 2010;(1):38–43. (in Russ.)

5. Alawamlh O.A.H., Goueli R., Lee R.K. Lower urinary tract symptoms, benign prostatic hyperplasia, and urinary retention. Med Clin North Am. 2018;102(2):301–11. DOI: 10.1016/j.mcna.2017.10.005

6. Roehrborn C.G. Prostatic urethral lift: a unique minimally invasive surgical treatment of male lower urinary tract symptoms secondary to benign prostatic hyperplasia. Urol Clin North Am. 2016;43(3):357–69. DOI: 10.1016/j.ucl.2016.04.008

7. Chen C.B., Chou C.T., Chen Y.L. Cone-beam CT findings during prostate artery embolization for benign prostatic hyperplasia-induced lower urinary tract symptoms: a case report. BMC Urol. 2017;17(1):120. DOI: 10.1186/s12894-017-0311-6

8. Baikov D.E., Kalacheva E.I., Kim D.A., Ryakhovskiy A.E., Shingareeva L.A., Baikova G.V. Computer tomography in diagnosis of diseases and new formations of the prostate gland. Creative surgery and oncology. 2017;7(2):22–7. DOI: 10.24060/2076-3093-2017-7-2-22-27 (in Russ.)

9. Kaprin A.D., Kostin A.A., Rerberg A.G., Ivanenko K.V., Pokatilov A.A., Luchkin V.M. An angio-interventional approach to treatment of benign prostatic hyperplasia with lower urinary tract syndrome. Urology and andrology. 2013;2(1):53–6. (in Russ.)

10. Atamanova E.A., Avdoshin V.P., Andryukhin M.I., Chugaev V.V. Prostate blood flow in patients with benign prostatic hyperplasia complicated by urine retention. RUDN journal of medicine. 2012;(4):83–6. (in Russ.)

11. Semyonychev D.V., Sevryukov F.A., Sorokin D.A., Karpukhin I.V., Puchkin A.B., Kochkin A.D., et al. Comparative evaluation of the effectiveness of various energy blocks in the bipolar prostate surgery. Pacific Medical Journal. 2017;(1):88–90. DOI: 10.17238/PmJ1609-1175.2017.1.88-90 (in Russ.)

12. Lourenco Т., Pickard R., Vale L., Grant A., Fraser C., MacLennan G., et al. Benign prostatic enlargement team. Minimally invasive treatments for benign prostatic enlargement: systematic review of randomised controlled trials. Br Med J. 2008;337(7676):966–9. DOI: 10.1136/bmj.a1662

13. Wang M.Q., Guo L.P., Zhang G.D., Yuan K., Li K., Duan F., et al. Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (> 80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population. BMC Urol. 2015;15:33. DOI 10.1186/s12894-015-0026-5

14. Pisco J., Campos Pinheiro L., Bilhim T., Duarte M., Rio Tinto H., Fernandes L., et al. Prostatic arterial embolization for benign prostatic hyperplasia: short- and intermediate-term results. Radiology. 2013;266(2):668–77. DOI: 10.1148/radiol.12111601

15. Pisco J.M., Pinheiro L.C., Bilhim T., Duarte M., Mendes J.R., Oliveira A.G., et al. Prostatic arterial embolization to treat benign prostatic hyperplasia. J Vase Interv Radiol. 2011;22(1):11–9. DOI: 10.1016/j.jvir.2010.09.030